Mysimba 8 mg/90 mg tabletten met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mysimba-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Bupropion and naltrexone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp114449",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "CYSTEINE(L-)HYDROCHLORIDE 0-WATER (E 920)",
    "DINATRIUMEDETAAT 0-WATER",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BUPROPIONHYDROCHLORIDE",
    "NALTREXONHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2015/03/26",
  "procedure_number": "EMEA/H/C/003687",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/988",
  "additional_monitoring": "Y"
}